EUVIMEDEUVIMED entdecken
Crossref

Lower C3 and C4 Complement Serum Levels Are Associated with More Severe Forms of COVID-19 Disease

Melanie-Ivana Čulo iD, Ivan Marković, Ana Šavuk, Nikola Zagorec, Tatjana Kereš, Danijela Grizelj, Ante Lisičić, Nikša Bušić, Sara Šakota, Marta Kmet, Tomislav Kelava, Ana Livun und 1 weitere

Viral Immunology · 2025-09 · 38 (7) · 245-253

DOI: 10.1177/08828245251362439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, online erschienen am 12.09.2025. Verfasst von Melanie-Ivana Čulo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia. Hauptthemen laut MEDLINE: COVID-19, Complement C4, Complement C3. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In a subgroup of patients, coronavirus disease (COVID)-19 is a severe illness with high mortality due to hyperinflammation, development of acute respiratory distress syndrome, and multiorgan dysfunction syndrome. Complement system activation plays a critical role in the pathogenesis and severity of COVID-19 disease.

Methods

This cross-sectional, single-center study aimed to investigate the correlation between serum C3 and C4 levels and COVID-19 severity. We included 125 patients hospitalized between December 2020 and March 2021. Patients were stratified into three groups based on the level of respiratory support needed to maintain adequate oxygenation (PaO 2 ≥ 60 mmHg): 51 patients requiring oxygen supplementation up to 15 L/min, 51 patients requiring high-flow oxygen therapy, and 23 patients requiring mechanical ventilation (MV). We analyzed the blood counts and serum levels of C3, C4, C-reactive protein (CRP), IL-6, procalcitonin, d-dimers, high-sensitive troponin I (TnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), IgA, IgG, IgM, C3, C4, rheumatoid factor, and anticitrullinated peptide antibodies.

Results

Patients on MV had significantly lower levels of C3 and C4 (0.98 ± 0.24 g/L for C3 and 0.21 ± 013 g/L for C4) compared with patients with less severe disease ( p < 0.001 for C3, p < 0.001 for C4). Serum C3 and C4 levels were lower in patients requiring high-flow oxygen therapy than in those requiring oxygen supplementation, however, the difference was not statistically significant. In addition, higher neutrophil counts were observed in patients on MV or high-flow oxygen therapy than in those on oxygen supplementation, and higher CRP, procalcitonin, and NT-proBNP levels were observed only in patients on MV. The levels of IL-6, d-dimers, and high-sensitive TnI were positively correlated with disease severity, whereas lymphocyte counts showed a negative correlation, and these differences were statistically significant among all three groups.

Conclusion

The determination of serum levels of C3 and C4, along with other known laboratory risk factors, may contribute to the detection of patients at an increased risk for severe COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Complement C4Complement C3HumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedSeverity of Illness IndexSARS-CoV-2AdultBiomarkersC-Reactive ProteinAged, 80 and overRespiration, Artificial

Stichwörter der Autor:innen

COVID-19anticitrullinated peptide antibodiescomplement system proteinsimmunoglobulinsrheumatoid factor

Substanzen

Complement C4Complement C3C3 protein, humanBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia.
  • Special Hospital for Pulmonary Diseases, Zagreb, Croatia.
  • Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia.
  • Department of Emergency and Intensive Care Medicine, Dubrava University Hospital, Zagreb, Croatia.
  • Department of Cardiovascular disease, Dubrava University Hospital, Zagreb, Croatia.
  • Clinical Department of Laboratory Diagnostics, Dubrava University Hospital, Zagreb, Croatia.

ORCID-Profile: Melanie-Ivana Čulo

Zitieren

APA

Čulo, M. I., Marković, I., Šavuk, A., Zagorec, N., Kereš, T., Grizelj, D., Lisičić, A., Bušić, N., Šakota, S., Kmet, M., Kelava, T., Livun, A., & Svaguša, T. (2025). Lower C3 and C4 Complement Serum Levels Are Associated with More Severe Forms of COVID-19 Disease. Viral Immunology, 38(7), 245-253. https://doi.org/10.1177/08828245251362439

Vancouver

Čulo MI, Marković I, Šavuk A, Zagorec N, Kereš T, Grizelj D, et al. Lower C3 and C4 Complement Serum Levels Are Associated with More Severe Forms of COVID-19 Disease. Viral Immunology. 2025;38(7):245-253. doi:10.1177/08828245251362439

BibTeX
@article{ulo2025,
  author = {Čulo, Melanie-Ivana and Marković, Ivan and Šavuk, Ana and Zagorec, Nikola and Kereš, Tatjana and Grizelj, Danijela and Lisičić, Ante and Bušić, Nikša and Šakota, Sara and Kmet, Marta and Kelava, Tomislav and Livun, Ana and Svaguša, Tomo},
  title = {Lower C3 and C4 Complement Serum Levels Are Associated with More Severe Forms of COVID-19 Disease},
  journal = {Viral Immunology},
  year = {2025},
  volume = {38},
  number = {7},
  pages = {245--253},
  doi = {10.1177/08828245251362439}
}
Kostenlos starten →